Oxford University spinout Dark Blue Therapeutics acquired to advance leukaemia treatment
Oxford University spinout Dark Blue Therapeutics has been acquired by global biotechnology company Amgen in a deal worth up to US$840 million, marking a major milestone for Oxford-led cancer research and innovation.
Read more
MRC Translational Immune Discovery Unit
Pioneering the future in the study of human immunity to uncover the molecular pathways driving immune-mediated diseases.
MRC Molecular Haematology Unit
Understanding how mature blood cells are normally made from stem cells and how this is perturbed in common blood disorders.
Centre for Computational Biology
Using computational biology to help understand complex biological systems and combat a range of human diseases.
Latest publications
Protecting lactoferrin for iron delivery: Effects of matrix composition and iron loading on gastric stability
Journal article
Blanco-Doval A. et al, (2026), Food Hydrocolloids, 174
The 9th International RASopathies Symposium.
Journal article
Castel P. et al, (2026), Am J Med Genet A
A functional overlap between actively transcribed genes and chromatin insulator elements.
Journal article
Cornell LJ. et al, (2026), EMBO J
Protocol for stable cell line production to express muscle-type nicotinic receptor.
Journal article
Li A. et al, (2026), STAR Protoc, 7
Gain and Loss of FLT3 Mutations in Patients with Acute Myeloid Leukemia: A Noninterventional Cohort Study (CLEVO).
Journal article
Papayannidis C. et al, (2026), Oncol Ther
Upcoming Seminars
From Stem Cells in Leukemia to Neurons in Pancreatic Cancer
Tuesday, 31 March 2026, 1pm to 2pm
Speaker(s): Professor Andreas Trumpp
Series: Molecular Haematology Unit, WIMM
Targeting mitochondria in hematopoiesis
Tuesday, 14 April 2026, 1pm to 2pm
Speaker(s): Dr Els Mansell
Series: Molecular Haematology Unit, WIMM
Using experimental Medicine and pre-clinical models to understand human immunity
Thursday, 30 April 2026, 12pm to 1pm
Speaker(s): Professor Menna Clatworthy
Series: WIMM THURSDAY SEMINARS
Uncovering structural determinants of peptide recognition by public and private T-cell receptors
Friday, 01 May 2026, 9.15am to 10.15am
Speaker(s): Dr Maya Pidoux, Dr Caner Akil
Series: MRC TIDU Friday Morning Lab Meetings